Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
Bladder cancer is among most common malignancies worldwide, with significant morbidity and mortality. Conventional treatment strategies for bladder cancer include transurethral resection, radical cystectomy and chemotherapy. However, the complex immune landscape of bladder cancer involves innate and...
Saved in:
Main Authors: | Beatriz Ramos, Dakota Rogers |
---|---|
Format: | Article |
Language: | English |
Published: |
Asian Medical Press Ltd.(H.K.)
2025-02-01
|
Series: | Annals of Urologic Oncology |
Subjects: | |
Online Access: | http://auo.asmepress.com/articles/new-53-542.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis
by: Zihao Chen, et al.
Published: (2025-01-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01) -
Recent advances of nanovaccines on cancer theranostics
by: Xiaobing Yuan, et al.
Published: (2025-02-01) -
Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy
by: Xiangrui Zhang, et al.
Published: (2025-01-01) -
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01)